Sharmila Rao

Senior Consultant at Princeton Capital Advisors
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
New York City Metropolitan Area
Languages
  • Hindi -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Biostatistics in Public Health
    Coursera
    Aug, 2020
    - Oct, 2024

Experience

    • United States
    • Business Consulting and Services
    • 1 - 100 Employee
    • Senior Consultant
      • May 2021 - Present

      Senior consultant at health and biopharma focused advisory firm. Worked on strategic advisory assignments for small and mid-sized biotechnology, pharmaceutical and medical device companies. Senior consultant at health and biopharma focused advisory firm. Worked on strategic advisory assignments for small and mid-sized biotechnology, pharmaceutical and medical device companies.

    • United States
    • Business Consulting and Services
    • 700 & Above Employee
    • Associate
      • Feb 2017 - May 2017

      Part of a major procurement strategy and implementation project for a multinational medical products and pharmaceutical company. Evaluated product supply chains for procurement of innovative and disruptive technologies. Reviewed industry trends, market dynamics and competitive strategies. Assessed opportunities for improved strategic positioning through long-term partnerships. Developed and completed work products to influence a wide range of stakeholders, including commercial and research & development leaders. Show less

    • United Kingdom
    • Research Services
    • 1 - 100 Employee
    • Associate Consultant
      • 2005 - 2008

      Executed physician and market research for pharmaceutical and biotech companies to assess the therapeutic and commercial potential of novel drugs for treatment of range of cancers. Assessed market gaps and unmet therapeutic treatment needs in a range of cancers. Reviewed ongoing clinical development strategies of competitors, and evaluated total addressable market size for key chemotherapies. Interviewed numerous academic and clinical key opinion leaders across multiple markets to understand patient segmentation, unmet needs, future trends, and likely competitive positions of novel drugs in future treatment strategies. Identified commercially important treatment opportunities for several cancers including Large B-cell Lymphoma (DLBC), Multiple Myeloma (MM), Non-Small Cell Lung Cancer (NSCLC), Hepatocecullar Carcinoma (HCC) and Ovarian Cancer. Show less

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Financial Analyst
      • Aug 2001 - Nov 2003

      Provided financial and strategic planning support for Merck emerging market business units. Involved in corporate strategy development, financial planning, and forecasting in Eastern European, Middle East, and Africa markets. Provided finance and strategic planning as part of a corporate development team involved in an international acquisition. Developed financial forecasts for alternative market scenarios and assessed valuation impacts. Supported regional business unit leadership in reviewing and evaluating capital projects and growth initiatives. Show less

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Senior Research Fellow
      • 1998 - 2000

      Lead scientist and project leader in a clinical research project investigating prostate cancer funded by Milken Institute / Prostate Cancer Foundation. Coordinated a multidisciplinary team involving oncologists, cancer surgeons, pathologists, nurses and researchers. Mentored and advised 5 PhD-level graduate students. Lead scientist and project leader in a clinical research project investigating prostate cancer funded by Milken Institute / Prostate Cancer Foundation. Coordinated a multidisciplinary team involving oncologists, cancer surgeons, pathologists, nurses and researchers. Mentored and advised 5 PhD-level graduate students.

    • United States
    • Wellness and Fitness Services
    • 700 & Above Employee
    • Postdoctoral Fellow
      • 1996 - 1998

      Postdoctoral fellow focused on molecular targeting of breast cancers. Discovered potential use of Mevacor (Lovastatin) in preventing breast cancer cell proliferation. Results were published in Proceeding of the National Academy of Sciences. Published 4 papers in top 10 science journals, managed laboratory research team under a multi-year US Army grant. Postdoctoral fellow focused on molecular targeting of breast cancers. Discovered potential use of Mevacor (Lovastatin) in preventing breast cancer cell proliferation. Results were published in Proceeding of the National Academy of Sciences. Published 4 papers in top 10 science journals, managed laboratory research team under a multi-year US Army grant.

Education

  • Cornell University - Johnson Graduate School of Management
    Master of Business Administration (M.B.A.), Business Strategy and Finance
    2000 - 2001
  • The Graduate Center, City University of New York
    Doctor of Philosophy (Ph.D.), Biochemistry and Molecular Biology
    1991 - 1996
  • St. Xavier's College
    Bachelor of Science - BS, Biochemistry and Molecular Biology
    1989 - 1991

Community

You need to have a working account to view this content. Click here to join now